申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05212320A1
公开(公告)日:1993-05-18
Indole derivatives of the formula ##STR1## and pharmaceutical compositions thereof. They are useful for treating or preventing testosterone 5-alpha-reductase-mediated diseases, such as alopecia, acnes and prostatism.
该公式的吲哚衍生物及其药物组合物。它们可用于治疗或预防睾酮5α-还原酶介导的疾病,如脱发、粉刺和前列腺增生。